Print this page
-
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab versus Relatlimab and Nivolumab in Participants with Unresectable or Metastatic Melanoma.
Protocol: 092402Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients.
Protocol: 092601Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
Understanding Sun Protection and Skin Examination Practices Among Hispanics.
Protocol: 132111Principal Investigator:
- Carolyn J Heckman
Applicable Disease Sites: Melanoma, Skin -
A Digital Intervention to Improve Skin Self-Examination Among Melanoma Survivors.
Protocol: 132202Principal Investigator:
- Sharon Manne
Applicable Disease Sites: Melanoma, Skin
- 1
- 2